• logo
  • CanadaCanada
  • Products
    • Search for Product
      • Product Name

        Keyword Search

    • Featured Products
        • TILCOMED

          TilcoMed®

        • FERROFORTE

          FERROFORTE

  • News
  • Library
  • Facilities
  • Regions
  • Contacts
Stalosan F
Coseicure Cattle Bolus - Improve your pregnancy rates

Global Excellence in Animal Health

Bimeda® is a leading global manufacturer, marketer and distributor of animal health products and veterinary pharmaceuticals. Through ongoing expansion and strategic acquisition, Bimeda® has established markets in more than seventy countries worldwide and has R&D, manufacturing and distribution capabilities across Europe, North America, South America, Africa, Asia and Australasia. Bimeda® employs almost 800 employees worldwide and has its global headquarters in Carrickmines, Dublin, Ireland. Bimeda is focused on providing a comprehensive, customer-driven service, selling consistently high-quality products, at a market-conscious price level.

Bimeda® Canada’s operations are located in Cambridge, Ontario, where the manufacturing facility has been in operation since 1964. As the leading Canadian manufacturer of sterile veterinary pharmaceuticals, the Bimeda® Canada product range includes metabolic fluids, vitamin/minerals, and anti-inflammatories. Bimeda® Canada’s extensive range includes products for the swine, dairy, beef and equine sectors. Bimeda® Canada manufactured products are sold worldwide under the Bimeda brand.

Visit Bimeda.com to learn more.

Bimeda Global

global map

Bimeda News

Published: December 13, 2019
Bimeda is pleased to announce the acquisition of Texas Vet Lab, Inc (TVL). Established in 1977 and located in San Angelo, Texas, TVL specialises in bovine vaccine research and production, with a broad range of live and inactivated vaccines to protect against cattle respiratory diseases. Company CEO Gavin Tierney, commented;…
Published: December 13, 2019
Bimeda is pleased to announce its acquisition of the Grupo Unipharm veterinary medicine portfolio, consisting of 25 licensed veterinary products and over 150 licenses. The acquisition will further strengthen Bimeda’s presence in Central America, which is regarded as a region with significant growth potential. Carlos Porragas, Bimeda Director for Latin…